Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Demasi

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Clinical Orthopaedics and Related Research|May 1, 1991
Bone mineral content at three sites in normal perimenopausal womenM D Carter, G Lester, R DeMasi, et al.
HIV Medicine|February 28, 2013
Pharmacokinetic interaction between etravirine or darunavir/ritonavir and artemether/lumefantrine in healthy volunteers: a two-panel, two-way, two-period, randomized trialT N Kakuda, R DeMasi, Y van Delft, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|June 13, 2006
Genotypic changes in human immunodeficiency virus type 1 envelope glycoproteins on treatment with the fusion inhibitor enfuvirtide and their influence on changes in drug susceptibility in vitroC Su, T Melby, R DeMasi, et al.
AIDS (London, England)|August 16, 2001
Overview of the effectiveness of triple combination therapy in antiretroviral-naive HIV-1 infected adultsJ A Bartlett, R DeMasi, J Quinn, et al.
The American Surgeon|January 1, 1994
Heparin-induced thrombocytopeniaR Demasi, A P Bode, C Knupp, et al.
Journal of Clinical Gastroenterology|December 17, 1998
Extremely high levels of alkaline phosphatase in hospitalized patientsO Maldonado, R Demasi, Y Maldonado, et al.
AIDS Research and Human Retroviruses|January 11, 2008
Evolution of genotypic and phenotypic resistance during chronic treatment with the fusion inhibitor T-1249T Melby, R Demasi, N Cammack, et al.
Transplantation|January 1, 1992
Prolongation of xenograft survival after combination therapy with 15-deoxyspergualin and total-lymphoid irradiation in the hamster-to-rat cardiac xenograft modelW Marchman, D Araneda, R DeMasi, et al.
AIDS (London, England)|June 6, 2000
Viral genetic heterogeneity in HIV-1-infected individuals is associated with increasing use of HAART and higher viremiaL Ross, M Johnson, R DeMasi, et al.
Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research|January 1, 1991
Improved xenograft survival with continuous infusion deoxyspergualin and RATGR DeMasi, D Araneda, U Gross, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Clinical Orthopaedics and Related Research|May 1, 1991
Bone mineral content at three sites in normal perimenopausal womenM D Carter, G Lester, R DeMasi, et al.
HIV Medicine|February 28, 2013
Pharmacokinetic interaction between etravirine or darunavir/ritonavir and artemether/lumefantrine in healthy volunteers: a two-panel, two-way, two-period, randomized trialT N Kakuda, R DeMasi, Y van Delft, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|June 13, 2006
Genotypic changes in human immunodeficiency virus type 1 envelope glycoproteins on treatment with the fusion inhibitor enfuvirtide and their influence on changes in drug susceptibility in vitroC Su, T Melby, R DeMasi, et al.
AIDS (London, England)|August 16, 2001
Overview of the effectiveness of triple combination therapy in antiretroviral-naive HIV-1 infected adultsJ A Bartlett, R DeMasi, J Quinn, et al.
The American Surgeon|January 1, 1994
Heparin-induced thrombocytopeniaR Demasi, A P Bode, C Knupp, et al.
Journal of Clinical Gastroenterology|December 17, 1998
Extremely high levels of alkaline phosphatase in hospitalized patientsO Maldonado, R Demasi, Y Maldonado, et al.
AIDS Research and Human Retroviruses|January 11, 2008
Evolution of genotypic and phenotypic resistance during chronic treatment with the fusion inhibitor T-1249T Melby, R Demasi, N Cammack, et al.
Transplantation|January 1, 1992
Prolongation of xenograft survival after combination therapy with 15-deoxyspergualin and total-lymphoid irradiation in the hamster-to-rat cardiac xenograft modelW Marchman, D Araneda, R DeMasi, et al.
AIDS (London, England)|June 6, 2000
Viral genetic heterogeneity in HIV-1-infected individuals is associated with increasing use of HAART and higher viremiaL Ross, M Johnson, R DeMasi, et al.
Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research|January 1, 1991
Improved xenograft survival with continuous infusion deoxyspergualin and RATGR DeMasi, D Araneda, U Gross, et al.
Pageof 3